0.03Open0.03Pre Close0 Volume4.50K Open Interest1.00Strike Price0.00Turnover604.82%IV126.87%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.2211Delta0.9288Gamma15.16Leverage Ratio-0.0095Theta0.0000Rho3.35Eff Leverage0.0002Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet